Company intelligence / Profile preview

Neurex AI

London, England, United Kingdomthoughti.com ↗

Ownership: Private
Development stage: Other

Overview

Neurex AI offers an advanced generative AI platform designed to automate and optimize clinical documentation, medical coding, billing processes, patient data integration, and care continuum management in healthcare settings. The system integrates with EHRs to streamline workflows from pre-care through post-care billing with high accuracy in coding and documentation.

Therapeutic areas: Other
Modalities: Software/Artificial Intelligence Platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Not publicly disclosed as of June 2025

Beyond the preview

Go deeper on Neurex AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurex AI.

Explore the full profile